Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years
Clinical trial NCT05716347 · TERMINATED
Trial details
- NCT number
- NCT05716347
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2023-09-13
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.